DNAM1 and 2B4 Costimulatory Domains Enhance the Cytotoxicity of Anti-GPC3 Chimeric Antigen Receptor-Modified Natural Killer Cells Against Hepatocellular Cancer Cells in vitro

PURPOSE: Hepatocellular cancer (HCC) is the sixth most prevalent cancer and the third leading cause of cancer-related death worldwide. Cellular immunotherapy against glypican 3 (GPC3) has recently been used in the treatment of HCC, following the success of chimeric antigen receptor (CAR)-T therapy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yao, Zeng, Jianxing, Liu, Teng, Xu, Qingyi, Song, Xianglin, Zeng, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217313/
https://www.ncbi.nlm.nih.gov/pubmed/32440221
http://dx.doi.org/10.2147/CMAR.S253565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217313/
https://www.ncbi.nlm.nih.gov/pubmed/32440221
http://dx.doi.org/10.2147/CMAR.S253565

Ejemplares similares